News
Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and privacy violations.
Kennedy announced that all 17 will be leaving their posts, saying that "a clean sweep is needed to re-establish public confidence in vaccine science." Kennedy said that the committee, known as the ...
Global biopharmaceutical company GlaxoSmithKline (GSK) has pledged $300,000 to UW’s School of Pharmacy for its new Pharmacy Innovation in Immunization Research Collaborative (PIIRC) initiative. On ...
On EV/NPV, GSK trades c15% below European non-obesity peers (0.70x versus 0.82x) and c30% below the value of marketed assets alone," said Berenberg, which reiterated its £16.00 target price.
The husband of “King of the Hill” star actor Jonathan Joss alleged that the voice actor was murdered by a homophobic neighbor after enduring “years” of violent threats on their street.
GSK acquired both Jemperli (co-developed with AnaptysBio) and Zejula through its $5.31 billion acquisition of Tesaro in 2019. After the FDA’s accelerated approval in 2021 for patients with mismatch ...
The man allegedly responsible for fatally shooting “King of the Hill” voice actor Jonathan Joss is behind bars, The Post can confirm. The suspect, Sigfredo Alvarez Ceja, was taken into custody ...
SAN ANTONIO, Texas (WJW) — Actor Jonathan Joss, best known for his voice work in the animated sitcom “King of the Hill,” has died in an apparent shooting in Texas. According to multiple reports, the ...
Jonathan Joss, 59, who voiced the character John Redcorn in the animated series “King of the Hill,” was shot and killed over the weekend in San Antonio, Texas. On Sunday at around 7 p.m ...
GSK does look decent value though, with a price-to-earnings ratio of 9.6. The 18 analysts offering 12-month forecasts have a median target of 1,648p. If correct, that’s a modest 9% gain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results